D
Cidara Therapeutics, Inc. CDTX
$19.44 $0.261.36% NASDAQ
Recommendation
Prev Close
$19.44
Volume
112,586
Avg Vol (90D)
128,209
Market Cap
$212.94M
Dividend & Yield
--
52-Week Range
$10.00 - $28.42
P/E (TTM)
--
EPS (TTM)
-$30.09
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Cidara Therapeutics (NASDAQ:CDTX) Upgraded at StockNews.com
4/19/2025 - Ticker Report
Cidara Therapeutics (NASDAQ:CDTX) Upgraded to "Sell" at StockNews.com
4/17/2025 - MarketBeat
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors
4/16/2025 - Globe Newswire
Cidara Therapeutics (CDTX, $20) entered Uptrend as Momentum indicator ascends above 0 level on Apr 15, 2025
4/16/2025 - Tickeron - Technical Analysis
Cidara Therapeutics (CDTX, $20) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 15, 2025
4/16/2025 - Tickeron - Technical Analysis
Cidara Therapeutics' (CDTX) "Buy" Rating Reaffirmed at Needham & Company LLC
4/12/2025 - MarketBeat
Cidara Therapeutics (CDTX, $18.21) Stochastic Oscillator left the oversold zone on April 11, 2025
4/12/2025 - Tickeron - Stocks
Cidara Therapeutics (CDTX, $17.1) RSI Indicator left the oversold zone on April 08, 2025
4/9/2025 - Tickeron - Technical Analysis
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of "Buy" from Analysts
4/8/2025 - MarketBeat
Cidara Therapeutics (NASDAQ:CDTX) Raised to Sell at StockNews.com
4/7/2025 - MarketBeat
Cidara Therapeutics (CDTX, $16.43) RSI Indicator left the oversold zone on April 04, 2025
4/5/2025 - Tickeron - Stocks
Short Interest in Cidara Therapeutics, Inc. (NASDAQ:CDTX) Expands By 21.9%
4/4/2025 - MarketBeat
Cidara Therapeutics (CDTX, $18.37) RSI Indicator left the oversold zone on April 03, 2025
4/4/2025 - Tickeron - Stocks
Cidara Therapeutics (CDTX, $18.37) Stochastic Oscillator left the oversold zone on April 02, 2025
4/3/2025 - Tickeron - Stocks
Cidara Therapeutics (NASDAQ:CDTX) Shares Pass Above 50 Day Moving Average - Time to Sell?
4/3/2025 - MarketBeat
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
4/1/2025 - GuruFocus
Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
4/1/2025 - GuruFocus
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
4/1/2025 - Globe Newswire
Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
4/1/2025 - Globe Newswire
Cidara Therapeutics (CDTX, $21.54) price exceeded its 50-day Moving Average on March 31, 2025
4/1/2025 - Tickeron - Technical Analysis
Cidara Therapeutics (CDTX, $21.54) entered Downtrend as Momentum indicator drops below 0 level on Mar 31, 2025
4/1/2025 - Tickeron - Technical Analysis
Cidara Therapeutics (CDTX, $22.39) Stochastic Oscillator left the oversold zone on March 28, 2025
3/29/2025 - Tickeron - Stocks
Cidara Therapeutics (CDTX, $22.39) entered Uptrend as Momentum indicator ascends above 0 level on Mar 28, 2025
3/29/2025 - Tickeron - Stocks
Cidara Therapeutics (CDTX, $21.58) Stochastic Oscillator left the oversold zone on March 27, 2025
3/28/2025 - Tickeron - Technical Analysis
Cidara Therapeutics (CDTX, $20.83) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2025
3/27/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$1.28M
EBITDA (TTM)
-$91.07M
EBIT (TTM)
-$91.22M
Net Income (TTM)
-$169.83M
Balance Sheet
Total Assets (Q)
$214.80M
Total Debt (Q)
$3.58M
Total Liabilities (Q)
$51.49M
Book Value Per Share (Q)
$14.92
Cash Flow
Cash from Operations (TTM)
-$72.75M
Cash from Investing (TTM)
-$129.00K
Cash from Financing (TTM)
$97.93M
Net Change in Cash (TTM)
$25.05M
Filings
Filing Date
Thursday, March 6, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Apr 21 and 25 (est)
Price History
Loading...
Beta
1.27
7-Day Total Return
11.28%
30-Day Total Return
-17.84%
60-Day Total Return
-10.83%
90-Day Total Return
-18.08%
Year to Date Total Return
-28.79%
1-Year Total Return
34.63%
2-Year Total Return
-13.98%
3-Year Total Return
21.50%
5-Year Total Return
-65.16%
52-week Low
Apr 22, 2024 - $10.00
52-week High
Jan 02, 2025 - $28.42
Valuation
Market Cap
$212.94M - Micro Cap
Enterprise Value
$26.69M
Price/Sales (TTM)
148.40
Price/Book (Q)
1.30
Dividends and Shares
Shares Outstanding
9.73M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.cidara.com
Phone Number
(858) 752-6170
Address
6310 Nancy Ridge Drive
San Diego, CA 92121
Country
United States
Year Founded
2012
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company’s product includes... more
NASDAQ 04/17/2025 4:00PM Eastern Quotes delayed